Nasdaq panel grants Bellevue Life Sciences continued listing; must meet public holders rule by Feb 2025

OSR Holdings, Inc.

Received Nasdaq notice Feb 2024 for failing minimum 300 public holders; plan approved with extension to Aug 13, 2024.
Did not regain compliance by Aug 13; requested hearing which stayed suspension.
Hearing held Oct 1, 2024; Panel granted continued listing on Oct 4, 2024.
Must demonstrate compliance with Listing Rule 5505 by Feb 17, 2025, with prompt notification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.